LYSOVETA™ by Aker BioMarine is the first offering of LPC-EPA/DHA to the research community, and we are currently actively encouraging increased research collaboration activity in the LPC-EPA/DHA space. In particular, scientists with an interest in fundamental and applied research relating to brain and eye health across the human lifespan are encouraged to get in touch with us.
Please contact us for more information on collaboration opportunities.